Key result
A hybrid gradient boosting machine learning model predicted 5-year all-cause death with a C-index of 0.77 in external validation, discriminating mortality better than SSII-2020.
Why the study?
Does a machine learning-based approach improve the prediction of 5-year mortality and treatment benefit between PCI and CABG compared to the SSII-2020 score in patients with 3-vessel or left main CAD?
Observational (n=9,162)
Yes
Does a machine learning-based approach improve the prediction of 5-year mortality and treatment benefit between PCI and CABG compared to the SSII-2020 score in patients with 3-vessel or left main CAD?
Answers are grounded in this paper and cite their sources.
A machine learning-based approach effectively predicts 5-year mortality and identifies heterogeneity in treatment benefit between CABG and PCI in patients with complex CAD, outperforming the traditional SYNTAX score II 2020.
BACKGROUND In patients with 3-vessel coronary artery disease (CAD) and/or left main CAD, individual risk prediction plays a key role in deciding between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). OBJECTIVES The aim of this study was to assess whether these individualized revascularization decisions can be improved by applying machine learning (ML) algorithms and integrating clinical, biological, and anatomical factors. METHODS In the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) study, ML algorithms (Lasso regression, gradient boosting) were used to develop a prognostic index for 5-year death, which was combined, in the second stage, with assigned treatment (PCI or CABG) and prespecified effect-modifiers: disease type (3-vessel or left main CAD) and anatomical SYNTAX score. The model's discriminative ability to predict the risk of 5-year death and treatment benefit between PCI and CABG was cross-validated in the SYNTAX trial (n = 1,800) and externally validated in the CREDO-Kyoto (Coronary REvascularization Demonstrating Outcome Study in Kyoto) registry (n = 7,362), and then compared with the original SYNTAX score II 2020 (SSII-2020). RESULTS The hybrid gradient boosting model performed best for predicting 5-year all-cause death with C-indexes of 0.78 (95% CI: 0.75-0.81) in cross-validation and 0.77 (95% CI: 0.76-0.79) in external validation. The ML models discriminated 5-year mortality better than the SSII-2020 in the external validation cohort and identified heterogeneity in the treatment benefit of CABG vs PCI. CONCLUSIONS An ML-based approach for identifying individuals who benefit from CABG or PCI is feasible and effective. Implementation of this model in health care systems-trained to collect large numbers of parameters-may harmonize decision making globally. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NCT03417050; SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries; NCT00114972).
No takes yet. Share an insight, caveat, or question.
Ninomiya et al. (2023) conducted an observational in 3-vessel coronary artery disease (CAD) and/or left main CAD (n=9,162). Machine learning algorithms (hybrid gradient boosting model) vs. SYNTAX score II 2020 (SSII-2020) was evaluated on 5-year all-cause death (C-index 0.77, 95% CI 0.76-0.79). A hybrid gradient boosting machine learning model predicted 5-year all-cause death with a C-index of 0.77 in external validation, discriminating mortality better than SSII-2020.
Synapse has enriched 10 related papers. Consider them for comparative context: